Tower Research Capital (TRC)’s Jin Medical International ZJYL Stock Holding History

Tower Research Capital (TRC)’s Portfolio ZJYL Stock Details ZJYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-5	Closed	-$56	–	5679
2025 Q3	$56	Sell	5 -612	-99%	-$7.81K	﹤0.01%	5141
2025 Q2	$8.02K	Buy	617 +235	+62%	+$3.58K	﹤0.01%	4028
2025 Q1	$5.68K	Buy	382 +183	+92%	+$3.04K	﹤0.01%	4098
2024 Q4	$3.1K	Buy	+199	New	+$6.24K	﹤0.01%	4715
2024 Q2	–	Sell	-426	Closed	-$32.7K	–	6052
2024 Q1	$32.7K	Buy	426 +419	+5,986%	+$61.3K	﹤0.01%	2580
2023 Q4	$1.74K	Sell	7 -36	-84%	-$1.22K	﹤0.01%	5331
2023 Q3	$1.01K	Buy	+43	New	+$548	﹤0.01%	5432

Other funds holding ZJYL

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

BIA

Bell Investment Advisors Oakland, California $681M AUM 18.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Tower Research Capital (TRC)'s ZJYL Position: Q4 2025 in Review

Tower Research Capital (TRC) sold out of Jin Medical International (ZJYL) in Q4 2025, closing a stake of 5 shares — an estimated $56 sold.

Tower Research Capital (TRC) first reported a position in ZJYL in Q3 2023 and held it in 7 quarters. The position peaked at $32.7K in Q1 2024. 10 funds tracked by Wall St. Rank hold ZJYL as of Q4 2025.

Tower Research Capital (TRC) reported no remaining Jin Medical International position as of Q4 2025 after selling out during the quarter.
Tower Research Capital (TRC) sold 5 Jin Medical International shares in Q4 2025, an estimated $56.
Tower Research Capital (TRC) first reported a position in Jin Medical International in Q3 2023 and held it in 7 quarters.
Tower Research Capital (TRC)'s Jin Medical International position peaked at $32.7K in Q1 2024.
10 funds tracked by Wall St. Rank held Jin Medical International as of Q4 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2025, filed 17 Feb 2026.